Detalles de la búsqueda
1.
Immune-Modulating Drug MP1032 with SARS-CoV-2 Antiviral Activity In Vitro: A potential Multi-Target Approach for Prevention and Early Intervention Treatment of COVID-19.
Int J Mol Sci
; 21(22)2020 Nov 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-33233817
2.
Efficacy and safety of MP1032 plus standard-of-care compared to standard-of-care in hospitalised patients with COVID-19: a multicentre, randomised double-blind, placebo-controlled phase 2a trial.
Lancet Reg Health Eur
; 37: 100810, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38076629
3.
Efficacy of MP1032 in hospitalised patients with COVID-19- authors' reply.
Lancet Reg Health Eur
; 38: 100857, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38328414
Resultados
1 -
3
de 3
1
Próxima >
>>